The OsteoGen surgically implanted bone growth stimulator is a useful
adjunct for the treatment of nonunions when surgery is already planned
or when patient compliance may be a concern. Because the OsteoGen is
totally surgically implanted, patients are assured of therapeutic
treatment directly at the nonunion site 24 hours a day for at least 6
months.
The OsteoGen bone growth stimulator is compatible
with bone graft surgery in the surgical treatments (internal and
external fixation) commonly used for the management of nonunions. They
include, but are not exclusive to:
- transverse
- segmented
- comminuted
The OsteoGen bone growth stimulator is commonly used for nonunions in the following areas:
- femur
- tibia
- fibula
- humerus
- clavicle
- ulna
- radius
In addition, the OsteoGen stimulator may be used as an adjunct
to internal/external fixation and autograft.
*MRI safety
information has not yet been established for OsteoGen Implantable Bone
Growth Stimulators. The FDA approved device trade name is the EBI
OsteoGen Implantable Growth Stimulator.
